Comparison of MRI, F-18 FDG, and 11C-choline PET/CT for their potentials in differentiating brain tumor recurrence from brain tumor necrosis following radiotherapy

Clinical Nuclear Medicine

Volumn 36, Issue 11, 2011, Pages 978-981

  Tan, Haibo ^a   Chen, Limin ^a   Guan, Yihui ^a   Lin, Xiangtong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

choline PET CT; FDG PET CT; MRI; radionecrosis; tumor recurrence

Indexed keywords

CHOLINE C 11; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER RADIOTHERAPY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMAGING SYSTEM; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; TUMOR NECROSIS; TUMOR RECURRENCE;

ADULT; AGED; BRAIN; BRAIN NEOPLASMS; CHOLINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NECROSIS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIATION INJURIES; YOUNG ADULT;

EID: 80053996980     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31822f68a6     Document Type: Article

References (25)

1. Hoffman JM. New advances in brain tumour imaging. Curr Opin Oncol. 2001;13:148-153. (Pubitemid 32433969)
2. Cao Y, Sundgren PC, Tsien CI, et al. Physiologic and metabolic magnetic resonance imaging in gliomas. J Clin Oncol. 2006;24:1228-1235. (Pubitemid 46622025)
3. Hollingworth W, Medina LS, Lenkinski RE, et al. A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumours. Am J Neuroradiol. 2006;27:1404-1411. (Pubitemid 44260118)
4. Del Sole A, Falini A, Ravasi L, et al. Anatomical and biochemical investigation of primary brain tumours. Eur J Nucl Med. 2001;28:1851-1872.
5. Benard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med. 2003;33:148-162. (Pubitemid 36577057)
6. Di Chiro G, Brooks RA. PET-FDG of untreated and treated cerebral gliomas. J Nucl Med. 1988;29:421-423.
7. Kushner M, Tobin M, Alavi A, et al. Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET. J Nucl Med. 1987;28:1667-1670.
8. DeGrado TR, Coleman RE, Wang S, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res. 2001;611:110-117. (Pubitemid 32095708)
9. Effert PJ, Bares R, Handt S, et al. Metabolic imaging of untreated prostate cancer by positron emission tomography with 18-fluorine-labeled deoxyglucose. J Urol. 1996;155:994-998.
10. Hara T, Kosaka N, Shinoura N, et al. PET imaging of brain tumor with [methyl-11C] choline. J Nucl Med. 1997;38:842-847. (Pubitemid 27251970)
11. Kennedy EP, Weiss SB. The function of cystidine coenzymes in the biosynthesis of phospholipid. J Biol Chem. 1956;222:193-214.
12. Zeisel SH. Choline phospholipid: signal transduction and carcinogenesis. FASEB J. 1993;7:551-557. (Pubitemid 23120902)
13. Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells; MNR application of the zero trans method. Anticancer Res. 1996;16:1375-1380.
14. Zeisel SH. Dietary choline: biochemistry, physiology, and pharmacology. Annu Rev Nutr. 1981;1:95-121.
15. Giovacchini G, Fallanca F, Landoni C, et al. C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: an initial experience. Clin Nucl Med. 2009;34:7-10.
16. Ohtani T, Kurihara H, Ishiuchi S, et al. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med. 2001;28:1664-1670. (Pubitemid 33036109)
17. Tian M, Zhang H, Oriuchi N, et al. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Eur J Nucl Med Mol Imaging. 2004;31:1064-1072. (Pubitemid 39050172)
18. Dooms GC, Hecht S, Brant-Zawadzki M, et al. Brain radiation lesions: MR imaging. Radiology. 1986;158:149-155. (Pubitemid 16172308)
19. Mikhael MA. Radiation necrosis of the brain: correlation between, computed tomography, pathology and dose distribution. J Comput Assist Tomogr. 1978;2:71-80. (Pubitemid 8260660)
20. Kingsley DPE, Kendall BE. CT of the adverse effects of therapeutic radiation of the central nervous system. Am J Neuroradiol. 1981;2:453-460. (Pubitemid 12246383)
21. Van Dellen JR, Danziger A. Failure of computerized tomography to differentiate between radiation necrosis and cerebral tumour. S Afr Med J. 1978; 53:171-172. (Pubitemid 8298180)
22. Valk PE, Dillon WP. Radiation injury of the brain. Am J Neuroradiol. 1991;12:45-62.
23. Van Laere K, Ceyssens S, Van Calenbergh F, et al. Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging. 2005;32:39-51. (Pubitemid 40142777)
24. Masahiro N, Tetsuo H. Brain tumor: detection with C-11 Choline PET. RSAN Radiology. 1997;202:497-503.
25. Hara T, Kondo T, Kosaka N. Use of 18F-Choline and 11C-Choline as contrast agents in positron emission tomography imaging guided stereotactic biopsy sampling of gliomas. J Neurosurg. 2003;99:474-479. (Pubitemid 37040406)